Latest News in the Life Sciences Industry
PR Newswire Association LLC.
Implantica announces publication of a new health economics study showing RefluxStop®'s superior cost-effectiveness in the treatment of GERD in the Italian Healthcare System
21 May 2026
GlobeNewswire
Synendos Therapeutics Starts Phase 2 Trial in Generalized Anxiety Disorder
20 May 2026
GlobeNewswire
Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors
20 May 2026
PR Newswire Association LLC.
Implantica submits final response to FDA in the PMA application for RefluxStop® for U.S. market approval
20 May 2026
GlobeNewswire
dacadoo and Bradesco Vida e Previdência Partner to Bring Digital Health Engagement to Millions in Brazil
19 May 2026
GlobeNewswire
Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer
19 May 2026
PR Newswire Association LLC.
Implantica announces new breakthrough long-term RefluxStop® data on severe sufferers presented at DDW 2026
19 May 2026
GlobeNewswire
Roche to present new data at ASCO 2026, reinforcing giredestrant's potential to transform the treatment paradigm in early breast cancer
19 May 2026
GlobeNewswire
Syneos Health Wins “Best Mobile App for Patient Engagement” in 2026 MedTech Breakthrough Awards
18 May 2026
GlobeNewswire
JASCAYD® (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment
18 May 2026
PR Newswire Association LLC.
Implantica presents the first quarter (Q1 2026) on May 22 at 15:00 CET
18 May 2026
PR Newswire Association LLC.
Johnson & Johnson Launches 'Gut Tunnel' Experience in Singapore to Highlight the Importance of Endoscopic Remission in IBD
18 May 2026
GlobeNewswire
New PSMAddition data show 58% lower risk of PSA progression with Pluvicto® in metastatic hormone-sensitive prostate cancer
17 May 2026
GlobeNewswire
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
15 May 2026
PR Newswire Association LLC.
Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
15 May 2026
GlobeNewswire
Oculis Publishes Results of 2026 Annual General Meeting and Announces Election of Gregory D. Perry to its Board of Directors
14 May 2026
Upcoming Events All Events
- October 2026
- Milan: CPHI Milan 2026
- Basel: 26th Annual Biotech in Europe Forum
- Yokohama: BioJapan